Skip to content
Updates in Targeted Therapy for NSCLC
Sequencing Drugs in mCRPC
Management of Immune-Related Adverse Events
T-Cell Lymphomas: New Therapeutic Approaches
Challenging Cases in Breast Cancer
Optimal Therapeutic Strategies in GI Cancers
Optimal Therapies in Genitourinary Cancers
Translating Clinical Trials' Results into Clinical Practice
Advances in Oncology 2019: Breast Cancer Update
Current State of Lung Cancer Screening
Moving the Needle on Bladder Cancer Survival: A Urologist's Perspective
Novel Therapeutic Strategies in Acute Myeloid Leukemia: Our Cup Runneth Over
Biosimilars as Front-Line Options for Cancer Care
Drug Brown and White Bagging - What is It and Where Does it Lead Us?
MEDPRO™ Talk - A Patient’s Perspective
Immunotherapy in Kidney & Bladder
Targeted Therapy in Prostate
Lung Targeted Therapies in NSCLC - EGFR, ALK, and ROS1
Immunotherapy in Lung Cancer
Lung Targeted Therapies in NSCLC - BRAF, RET, MET and NTRK
Lung Cancer Immunotheraphy Case Presentation
Case Presentation - Breast
Breast Targeted Therapy - HER2, CDK 4-6, PI3KCA
Post navigation
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok 
